pancreatin

Poland

Drugs containing this active substance

  • KREON 10 000

    The medicine is used to treat exocrine pancreatic insufficiency, which occurs when the pancreas does not produce a sufficient amount of digestive enzymes. It may be helpful in cases of cystic fibrosis, chronic pancreatitis, pancreatic cancer, or after the removal of the pancreas.

    Form: capsules, hard, intestinal

    Active substance Dosage
    pancreatin 150 mg

    ATC: A09AA02

    Manufacturer: Abbott Laboratories GmbH Mylan Germany GmbH

  • The medicine is used in children, adolescents, and adults with exocrine pancreatic insufficiency. This is a condition in which the pancreas does not produce enough digestive enzymes. It may occur, among other things, in cystic fibrosis, chronic pancreatitis, pancreatic cancer, or after the removal of the pancreas or stomach.

    Form: capsules, enteric-coated

    Active substance Dosage
    pancreatin 300 mg

    ATC: A09AA02

    Manufacturer: Abbott Laboratories GmbH, Neustadt Plant

  • The medicine is used to treat exocrine pancreatic insufficiency (e.g., in cystic fibrosis, chronic pancreatitis, after pancreatic removal, or in the case of pancreatic cancer). It helps to digest food and reduces symptoms such as abdominal pain, bloating, diarrhea, constipation, or fatty stools.

    Form: capsules, hard, intestinal

    Active substance Dosage
    pancreatin 35000 IU

    ATC: A09AA02

    Manufacturer: Abbott Laboratories GmbH, Werk Neustadt Mylan Germany GmbH

  • The medicine is used in children, adolescents, and adults for digestive disorders resulting from pancreatic insufficiency. It may help in cases of cystic fibrosis, chronic pancreatitis, pancreatic cancer, or after surgeries to remove part of the pancreas or stomach. It helps relieve abdominal pain and bloating and improves stool consistency.

    Form: capsules, hard, intestinal

    Active substance Dosage
    pancreatin 10 000 j.

    ATC: A09AA02

    Manufacturer: BGP Products, Unipessoal Lda.

  • The medicine is used in children, adolescents, and adults for digestive disorders resulting from pancreatic insufficiency (when the pancreas does not produce sufficient enzymes). This may apply to individuals with cystic fibrosis, chronic pancreatitis, pancreatic cancer, after removal of the pancreas or stomach, and in other clinical conditions.

    Form: capsules, hard, intestinal

    Active substance Dosage
    pancreatin 10 000 j.

    ATC: A09AA02

    Manufacturer: Viatris Healthcare Limited

  • The medicine is used in children, adolescents, and adults for digestive disorders resulting from pancreatic insufficiency. It may help in conditions such as cystic fibrosis, chronic pancreatitis, pancreatic cancer, or after the removal of part of the pancreas or stomach. It helps to reduce abdominal pain and bloating and improves stool consistency.

    Form: capsules, hard, intestinal

    Active substance Dosage
    pancreatin 10 000 j.

    ATC: A09AA02

    Manufacturer: Viatris Healthcare Limited

  • The medicine is used in case of digestive disorders resulting from pancreatic insufficiency (when the pancreas does not produce a sufficient amount of enzymes). It helps digest food, reduces abdominal pain and bloating, and improves stool consistency.

    Form: capsules, hard, intestinal

    Active substance Dosage
    pancreatin 10 000 j.

    ATC: A09AA02

    Manufacturer: Viatris Healthcare Limited

  • The medicine is used in case of digestive disorders resulting from pancreatic insufficiency (when the pancreas does not produce a sufficient amount of enzymes). It may be used in individuals with cystic fibrosis, chronic pancreatitis, pancreatic cancer, after removal of the pancreas or stomach, and in other conditions related to pancreatic problems. It helps to reduce abdominal pain and bloating and improves stool consistency.

    Form: capsules, hard, intestinal

    Active substance Dosage
    pancreatin 10 000 j.

    ATC: A09AA02

    Manufacturer: Viatris Healthcare Limited

  • The medicine is used to treat exocrine pancreatic insufficiency (when the pancreas does not produce enough enzymes). It helps digest food and reduces symptoms such as abdominal pain, bloating, diarrhea, constipation, or fatty stools. It may be used in people with cystic fibrosis, chronic pancreatitis, pancreatic cancer, or after part of the pancreas has been removed.

    Form: capsules, hard, intestinal

    Active substance Dosage
    pancreatin 300 mg

    ATC: A09AA02

    Manufacturer: Abbott Laboratories GmbH, Werk Neustadt Mylan Germany GmbH

  • The medicine is used in the case of exocrine pancreatic insufficiency in children, adolescents, and adults. This condition occurs when the pancreas does not produce a sufficient amount of enzymes to digest food. It may occur, among other things, in cystic fibrosis, chronic pancreatitis, pancreatic cancer, or after the removal of the pancreas or stomach.

    Form: capsules

    Active substance Dosage
    pancreatin Lipase 16 000 j. Ph. Eur., Amylase 11 500 j. Ph. Eur., Protease 900 j. Ph. Eur.

    ATC: A09AA02

    Manufacturer: Pharmaceutical Plants POLPHARMA S.A. Production Branch in Nowa Dęba

  • The medicine is used in children, adolescents, and adults with digestive disorders resulting from pancreatic insufficiency (e.g., in cystic fibrosis, chronic pancreatitis, pancreatic cancer, or after removal of the pancreas or stomach). It helps digest food, reduces abdominal pain and bloating, and improves stool consistency.

    Form: capsules

    Active substance Dosage
    pancreatin 8000 IU Ph. Eur. (lipase), 5750 IU Ph. Eur. (amylase), 450 IU Ph. Eur. (protease)

    ATC: A09AA02

    Manufacturer: Pharmaceutical Plants POLPHARMA S.A. Production Branch in Nowa Dęba

  • The medicine is used in cases of pancreatic enzyme deficiency, for example in chronic pancreatitis, cystic fibrosis, obstruction of the pancreatic or bile ducts (e.g., due to cancer), and after surgery to remove the pancreas or stomach.

    Form: capsules, enteric-coated

    Active substance Dosage
    pancreatin 140 mg

    ATC: A09AA02

    Manufacturer: Jelfa Pharmaceutical Enterprise S.A.

  • The medicine is used as a supplement to pancreatic enzymes in individuals experiencing digestive problems resulting from a lack or insufficient secretion of pancreatic enzymes. This may include, among others, people with chronic pancreatitis, cystic fibrosis, celiac disease, intestinal diseases, or diabetes.

    Form: capsules, hard, intestinal

    Active substance Dosage
    pancreatin 10000 j.

    ATC: A09AA02

    Manufacturer: Berlin-Chemie AG (Menarini Group)

  • The medicine is used as a supplement to pancreatic enzymes in individuals with digestive disorders resulting from their deficiency or insufficient secretion. This may occur, among other things, in chronic pancreatitis, cystic fibrosis, liver diseases, intestinal diseases, or diabetes.

    Form: capsules

    Active substance Dosage
    pancreatin 10 000 Ph.Eur. units lipase, 9 000 Ph.Eur. units amylase, 500 Ph.Eur. units protease

    ATC: A09AA02

    Manufacturer: Berlin-Chemie AG